Compare KPTI & RRGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KPTI | RRGB |
|---|---|---|
| Founded | 2008 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 94.6M | 88.7M |
| IPO Year | 2013 | 2002 |
| Metric | KPTI | RRGB |
|---|---|---|
| Price | $6.95 | $4.03 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | ★ $22.17 | $11.00 |
| AVG Volume (30 Days) | 165.8K | ★ 197.8K |
| Earning Date | 11-03-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $142,530,000.00 | ★ $1,226,409,000.00 |
| Revenue This Year | $3.82 | N/A |
| Revenue Next Year | $3.18 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.51 | $2.50 |
| 52 Week High | $12.45 | $7.89 |
| Indicator | KPTI | RRGB |
|---|---|---|
| Relative Strength Index (RSI) | 66.79 | 37.93 |
| Support Level | $5.70 | $3.85 |
| Resistance Level | $6.05 | $4.05 |
| Average True Range (ATR) | 0.45 | 0.18 |
| MACD | 0.16 | 0.07 |
| Stochastic Oscillator | 75.69 | 33.80 |
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.
Red Robin Gourmet Burgers Inc is a restaurant operator. The company develops, operates, and franchises casual-dining restaurants and fast-casual restaurants in North America. Its brands are Red Robin, Red Robin Gourmet Burgers, Red Robin America's Gourmet Burgers and Spirits, Red Robin Burger Works, YUMMM, Red Robin Gourmet Burgers and Brews, and Red Robin Royalty names and logos. The company's revenue consists of sales from restaurant operations, gift card breakage, franchise royalties and fees, and other miscellaneous revenue. The company has one operating and one reportable segment: restaurants.